Artemis Therapeutics Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Brightman Almagor Zohar & Co, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 USD | -25.00% | -25.00% | -58.33% |
1st Jan change | Capi. | |
---|---|---|
-58.33% | 3.36M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- MNKA Stock
- News Manuka, Inc.
- Artemis Therapeutics Inc. Auditor Raises 'Going Concern' Doubt